在减轻具有抗炎作用的糖尿病病中,SMTP-27的治疗潜力

Keita Shibata1, Taiki Awane1, Takashi Takaki2

  • 1Department of Pharmacology, Showa Medical University Graduate School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan; Pharmacological Research Center, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.

概括

一种新型化合物SMTP-27在治疗糖尿病病 (DN) 中具有前景. 这项研究表明它能够改善功能并减少DN小鼠模型中的炎症.